Venova Medical Announces $30 Million Series B Financing

Venova Medical, a UCSF-launched company developing a next-generation technology for the creation of percutaneous arteriovenous fistulas (pAVF) for hemodialysis access, announced the initial closing of a $30M Series B funding round. Catalyst Health Ventures and a leading medical device company co-led the financing, with participation from ShangBay Capital, Mirae Asset Capital, KOFA Healthcare, Cadence Healthcare Ventures, Aphelion Capital and other new and existing investors. The funding is being used to further develop the company's technology and conduct clinical studies in the U.S. to support FDA regulatory approval. 

Venova Medical also announced the appointment of Darshana Zaveri, Managing Partner at Catalyst Health Ventures, to the company's Board of Directors.

Shant Vartanian is the UCSF researcher and founder.